Eczema Breakthroughs cover art

Eczema Breakthroughs

Eczema Breakthroughs

By: Global Parents for Eczema Research (GPER)
Listen for free

About this listen

Interviews with the leading scientists and innovators, hosted by Global Parents for Eczema Research (GPER), a non-profit led by parents of children with eczema. Like what we're doing? Consider donating to GPER at: www.parentsforeczemaresearch.com/donate Do you enjoy this podcast? Rate it on Apple Podcasts, Google Podcasts or Spotify! Learn more about GPER and subscribe to this podcast at: parentsforeczemaresearch.orgCopyright 2025 Global Parents for Eczema Research (GPER) Biological Sciences Hygiene & Healthy Living Parenting & Families Physical Illness & Disease Relationships Science
Episodes
  • Staph’s secret superpower and their accomplice Streptococcus
    May 22 2025

    Two new studies from the Society for Investigative Dermatology (SID) conference reveal how Staph bacteria use clever strategies to disarm the skin's barrier maintenance function and work with other bacteria to amplify inflammation. Join us for an interview with Dr. Nathan Archer and Dr. Laine Feller from John Hopkins School of Medicine who explain how Staph aureus bacteria uses its superantigen superpower to hinder lipid production ... and more new research from this year's SID meeting.

    Show More Show Less
    14 mins
  • New nonsteroidal eczema cream approved for kids
    Apr 30 2025

    New treatment alert! The FDA recently approved Tapinarof, applied as a cream, for kids 2 years and up. We ask Dr. Leon Kircik from Icahn School of Medicine, NY, who led the clinical trials about the safety, efficacy and side effects of Tapinarof. And because we are parents too, we ask: How quickly does it work? Can you start/stop it as needed? How easy will it be to access? And more. If you like our podcast, please consider supporting it with a tax deductible donation.

    Research discussed

    Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and Children

    Maximal usage trial of tapinarof cream 1% once daily in pediatric patients down to 2 years of age with extensive atopic dermatitis

    Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials

    Tapinarof cream in the treatment of atopic dermatitis in children and adults a systematic review and meta-analysis

    Efficacy and safety of Ruxolitinib, Crisaborole, and Tapinarof for mild-to-moderate atopic dermatitis: a Bayesian network analysis of RCTs

    Show More Show Less
    22 mins
  • Hot off the press - What researchers are talking about at AAAAI Allergy Conference.
    Mar 20 2025

    What to look out for in eczema moisturizers, why eczema babies have rosy red cheeks and can allergies transfer to baby from breast milk? Join Korey Capozza, Dr. Jessica Hui-Beckman (National Jewish Health) and Dr. Kirsi Jarvinen-Seppo (University of Rochester) to find the answers. If you like our podcast, please consider supporting it with a tax deductible donation.

    Research discussed

    Consumer Preferences, Product Characteristics, and Potentially Allergenic Ingredients in Best-selling Moisturizers

    Early Life Cheek Skin Barrier Changes are Associated with Atopic Dermatitis Development

    Prevention of IgE-Mediated Food Allergy: Emerging Strategies Through Maternal and Neonatal Interventions


    Show More Show Less
    17 mins

What listeners say about Eczema Breakthroughs

Average Customer Ratings
Overall
  • 5 out of 5 stars
  • 5 Stars
    1
  • 4 Stars
    0
  • 3 Stars
    0
  • 2 Stars
    0
  • 1 Stars
    0
Performance
  • 5 out of 5 stars
  • 5 Stars
    1
  • 4 Stars
    0
  • 3 Stars
    0
  • 2 Stars
    0
  • 1 Stars
    0
Story
  • 5 out of 5 stars
  • 5 Stars
    1
  • 4 Stars
    0
  • 3 Stars
    0
  • 2 Stars
    0
  • 1 Stars
    0

Reviews - Please select the tabs below to change the source of reviews.

Sort by:
Filter by:
  • Overall
    5 out of 5 stars
  • Performance
    5 out of 5 stars
  • Story
    5 out of 5 stars

Fantastic

It's great to hear real information to help with conditions of eczema that are up to date, providing possible treatment of Dupilumab for eczema patients. Listening to the studies related to Covid and its effects is amazing. definitely have a listen, it's been a light to me in a room of darkness.

Something went wrong. Please try again in a few minutes.

You voted on this review!

You reported this review!

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.